Clinical Trial Update: A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating PET tracers 18F-AV-133 and 18F-AV-45 for imaging dementia with Lewy bodies …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia with Lewy Bodies

Drugs mentioned

• 18F-AV-45 (florbetapir)
• [18F] AV-133 (AV-133)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Dementia With Lewy Bodies, Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED